Cargando…
The Importance of Neonatal Screening for Galactosemia
Galactosemia is an inborn metabolic disorder caused by a deficient activity in one of the enzymes involved in the metabolism of galactose. The first description of galactosemia in newborns dates from 1908, ever since complex research has been performed on cell and animal models to gain more insights...
Autores principales: | Badiu Tișa, Ioana, Achim, Anca Cristina, Cozma-Petruț, Anamaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823668/ https://www.ncbi.nlm.nih.gov/pubmed/36615667 http://dx.doi.org/10.3390/nu15010010 |
Ejemplares similares
-
Determinants of Early Initiation of Breastfeeding among Mothers of Children Aged Less Than 24 Months in Northwestern Romania
por: Cozma-Petruţ, Anamaria, et al.
Publicado: (2019) -
Neonatal Screening: Cost-utility Analysis for Galactosemia
por: HATAM, Nahid, et al.
Publicado: (2017) -
Breastfeeding Practices and Determinant Factors of Exclusive Breastfeeding among Mothers of Children Aged 0–23 Months in Northwestern Romania
por: Cozma-Petruţ, Anamaria, et al.
Publicado: (2021) -
Screening for galactosemia: is there a place for it?
por: Kotb, Magd A, et al.
Publicado: (2019) -
The Discovery of GALM Deficiency (Type IV Galactosemia) and Newborn Screening System for Galactosemia in Japan
por: Kikuchi, Atsuo, et al.
Publicado: (2021)